The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98121063 9812106 3 F 20110523 20160706 20140111 20160725 EXP US-ROCHE-783279 ROCHE 65.39 YR M Y 91.80000 KG 20160725 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98121063 9812106 1 PS Vismodegib VISMODEGIB 1 Oral CYCLE = 28 DAYS?DATE OF LAST DOSE PRIOR TO ADVERSE EVENT 1: 22/MAY/2011?DATE OF LAST DOSE PRIOR TO A U 203388 CAPSULE
98121063 9812106 2 SS Vismodegib VISMODEGIB 1 Oral CYCLE = 28 DAYS U 203388 1000 MG CAPSULE
98121063 9812106 3 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1000MG/M2 IV OVER 30 MINUTES ON DAYS 1, 8, 15 STARTING WITH CYCLE 2 (DAY 29) U 0 1000 MG/M**2
98121063 9812106 4 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1000MG/M2 IV OVER 30 MINUTES ON DAYS 1, 8, 15 STARTING WITH CYCLE 2 (DAY 29) U 0 1000 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98121063 9812106 1 Adenocarcinoma pancreas
98121063 9812106 3 Adenocarcinoma pancreas

Outcome of event

Event ID CASEID OUTC COD
98121063 9812106 OT
98121063 9812106 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
98121063 9812106 Cognitive disorder
98121063 9812106 Dehydration
98121063 9812106 Neutrophil count decreased
98121063 9812106 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98121063 9812106 1 20110504 20110614 0
98121063 9812106 2 20110601 20110614 0